Clinical Trial Update: A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 Diabetes [Phase 1]

View source ↗

Summary

This clinical trial update reports the pharmacokinetic assessment of FIAsp (fast-acting insulin aspart) in children, adolescents, and adults with Type 1 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• FIAsp (Fiasp) (insulin aspart, fast-acting)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED